ARCHIVES

Bush Names 8 to NCAB.

This article is from The Cancer Letter archive.

Vol. 34 No. 23 | June 13, 2008

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

NCI spends A Third Of Its Budget On Prevention

May 15, 1992

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

In Brief: Pinedo To Receive Josef Steiner Prize; Lurie Cancer Center Gets $2.5M Donation

October 27, 1995

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013